Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Goodwill (2018 - 2025)

Historic Goodwill for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $285.6 million.

  • Health Catalyst's Goodwill rose 2184.38% to $285.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $285.6 million, marking a year-over-year increase of 2184.38%. This contributed to the annual value of $259.8 million for FY2024, which is 3624.77% up from last year.
  • As of Q3 2025, Health Catalyst's Goodwill stood at $285.6 million, which was up 2184.38% from $286.1 million recorded in Q2 2025.
  • Health Catalyst's 5-year Goodwill high stood at $313.4 million for Q1 2025, and its period low was $107.8 million during Q1 2021.
  • Moreover, its 5-year median value for Goodwill was $186.0 million (2022), whereas its average is $201.0 million.
  • In the last 5 years, Health Catalyst's Goodwill surged by 48538.47% in 2021 and then changed by 0.0% in 2023.
  • Over the past 5 years, Health Catalyst's Goodwill (Quarter) stood at $170.0 million in 2021, then grew by 9.42% to $186.0 million in 2022, then increased by 2.51% to $190.7 million in 2023, then soared by 36.25% to $259.8 million in 2024, then increased by 9.94% to $285.6 million in 2025.
  • Its last three reported values are $285.6 million in Q3 2025, $286.1 million for Q2 2025, and $313.4 million during Q1 2025.